Effects of Cigarette Smoking on Transplant Survival: Extending or Shortening It? by Feifei Qiu et al.
February 2017 | Volume 8 | Article 1271
PersPective
published: 10 February 2017
doi: 10.3389/fimmu.2017.00127
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Antoine Toubert, 
Paris Diderot University, France
Reviewed by: 
Zheng Jenny Zhang, 
Northwestern University, USA 
Federica Casiraghi, 
Mario Negri Institute for 
Pharmacological Research, Italy
*Correspondence:
Zhenhua Dai 
zdai2009@outlook.com
Specialty section: 
This article was submitted to 
Alloimmunity and Transplantation, 
a section of the journal 
Frontiers in Immunology
Received: 01 September 2016
Accepted: 25 January 2017
Published: 10 February 2017
Citation: 
Qiu F, Fan P, Nie GD, Liu H, 
Liang C-L, Yu W and Dai Z (2017) 
Effects of Cigarette Smoking on 
Transplant Survival: 
Extending or Shortening It? 
Front. Immunol. 8:127. 
doi: 10.3389/fimmu.2017.00127
effects of cigarette smoking  
on transplant survival: extending  
or shortening it?
Feifei Qiu1, Ping Fan2, Golay D. Nie3, Huazhen Liu1, Chun-Ling Liang1,  
Wanlin Yu1 and Zhenhua Dai1*
1 Section of Immunology, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China, 2 Department of 
Nephrology, Shaanxi Provincial Hospital of Chinese Medicine, Xi’an, China, 3 School of Medicine, University of Texas Medical 
Branch, Galveston, TX, USA
Cigarette smoking (CS) regulates both innate and adaptive immunity and causes numer-
ous diseases, including cardiovascular, respiratory, and autoimmune diseases, allergies, 
cancers, and transplant rejection. Therefore, smoking poses a serious challenge to the 
healthcare system worldwide. Epidemiological studies have always shown that CS is one 
of the major risk factors for transplant rejection, even though smoking plays redundant 
roles in regulating immune responses. The complex roles for smoking in immunoregula-
tion are likely due to molecular and functional diversities of cigarette smoke components, 
including carbon monoxide (CO) and nicotine. Especially, CO has been shown to induce 
immune tolerance. Although CS has been shown to impact transplantation by causing 
complications and subsequent rejection, it is overlooked whether CS interferes with 
transplant tolerance. We have previously demonstrated that cigarette smoke exposure 
reverses long-term allograft survival induced by costimulatory blockade. Given that CS 
impacts both adaptive and innate immunity and that it hinders long-term transplant sur-
vival, our perspective is that CS impacts transplant tolerance. Here, we review impacts 
of CS on major immune cells that are critical for transplant outcomes and propose the 
cellular and molecular mechanisms underlying its effects on alloimmunity and transplant 
survival. Further investigations are warranted to fully understand why CS exerts delete-
rious rather than beneficial effects on transplant survival even if some of its components 
are immunosuppressive.
Keywords: cigarette smoking, adaptive immunity, innate immunity, allograft survival, transplant tolerance
iNtrODUctiON
Cigarette smoking (CS) contributes to various diseases, including oral, respiratory, and cardiovas-
cular diseases, infections, cancers, autoimmune diseases, and transplant rejection. It impacts both 
adaptive and innate immunity. On the other hand, CS is a well-known risk factor associated with 
the morbidity and mortality of organ transplantation. Numerous epidemiological analyses and ret-
rospective reviews have shown that CS increases the risks of transplantation-related complications, 
allograft rejection, and recipient death in transplanted patients. Although the adverse impacts of 
smoking on outcomes of organ transplantation are well documented, the molecular and cellular 
mechanisms responsible for smoking-associated graft rejection are neither fully understood nor 
FiGUre 1 | Potential mechanisms by which cigarette smoking (cs) alters transplant rejection and interferes with transplant tolerance. CS represses 
the expression of IDO in dendritic cells (DCs) and Foxp3 in regulatory T cells (Tregs) and hence reduces the percentages of regulatory DCs as well as FoxP3+ Tregs, 
but increases the frequency of CD4+ or CD3+ memory T cells and IgG+/IgM+ memory B cells, likely resulting in transplant rejection or the loss of immune tolerance 
as the balance between pathogenic memory T/B cells and regulatory DCs/Tregs is interrupted by smoking. However, as a cigarette smoke component, carbon 
monoxide generally induces Tregs while nicotine promotes T cell anergy. Therefore, both CS components could suppress allograft rejection if sufficient amounts 
were inhaled.
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carefully proposed. Especially, it has been overlooked whether 
and how smoking directly impacts transplant tolerance, even 
with many of the original studies showing that CS has widely 
affected immune responses as well as transplantation outcomes. 
In the current review, we summarize the effects of smoking on the 
major immune cells that impact transplant survival or tolerance 
(Figure 1) and propose the molecular mechanisms that are likely 
responsible for CS-associated allograft rejection.
eFFects OF sMOKiNG ON  
trANsPLANt sUrvivAL
Growing studies have demonstrated that smoking hinders long-
term allograft survival by promoting various complications after 
transplantation. Pungpapong et al. reported that patients with a 
smoking history had higher risks of vascular complications, espe-
cially arterial ones than non-smokers after liver transplantation, 
while patients, who gave up smoking for 2 years prior to transplan-
tation, had lower incidence of vascular complications (1). Further 
studies revealed that CS was associated with increased incidence 
of biliary complication and higher hepatocellular carcinoma rates 
(2). Similarly, CS by both donors and recipients had negative 
impacts on outcomes of lung transplantation. Smoking by donors 
directly influenced the early postoperative events rather than the 
late outcomes (3). Studies on former and current smokers with 
lung transplantation demonstrated that smokers had higher 
incidence of decreased pulmonary function or chronic kidney 
disease, a common complication of lung transplantation, than 
non-smoking recipients (4). Moreover, pretransplantation smok-
ing by either donors or recipients significantly reduced recipient 
survival rates (5). CS after renal transplantation was associated 
with impaired renal function (6), vascular intimal fibrous thick-
ening, and higher incidence of diabetes (7). Adverse effects of 
smoking on heart transplantation were also reported. Nägele et al. 
found that smokers with heart transplantation had less long-term 
survivors and higher incidence of transplant vasculopathy than 
non-smokers (8). Pretransplantation and posttransplantation 
smoking not only resulted in a poorer prognosis and a longer 
period of recovery but also significantly raised overall mortality 
of patients (9–11).
Although numerous epidemiological studies supported the 
finding that CS is an important risk factor for organ transplanta-
tion, there was a lack of the proof that smoking can directly cause 
allograft failure in a cause-effect manner. Recently, our studies 
have provided the first evidence that second-hand smoking 
(SHS) directly prevents long-term allograft survival, which would 
otherwise have been induced by the costimulatory blockade in 
animal models (12). We found that SHS dramatically reduced 
the intragraft expression of indoleamine2,3-dioxygenase (IDO) 
while overexpression of IDO by islet allografts resumed long-term 
islet allograft survival induced by the costimulatory blockade even 
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in the face of SHS. Thus, we demonstrated that smoke exposure 
directly facilitated allograft rejection and interrupted transplant 
tolerance by repressing the expression and activity of IDO, which 
would otherwise have suppressed T cell activation and facilitated 
the immune tolerance (13).
iMPActs OF sMOKiNG ON MAJOr 
iMMUNe ceLLs tHAt MeDiAte 
trANsPLANt reJectiON Or PrOMOte 
GrAFt sUrvivAL
It is well known that allograft rejection can be suppressed or 
prevented by either global immunosuppression or targeted 
immunomodulation. The balanced activation of conventional 
dendritic cells (DCs), T cells and B cells, regulatory T cells (Treg) 
and regulatory B cells, and memory T and B cells is vital for the 
appropriate regulation of immunity, which determines trans-
plantation outcomes. Since CS impacts both innate and adaptive 
immunity, it likely also affects immune-based transplant rejection 
or allograft tolerance (Figure 1).
DeNDritic ceLLs
Dendritic cells, a critical subset of innate immune cells that serve 
as antigen-presenting cells, play an important role in mediating T 
cell activation as well as regulation of T cell function. Oberhuber 
et al. demonstrated that DCs expressing CD11c in murine recipi-
ents facilitated rejection of cardiac allograft and promoted the 
proliferation of both CD4+ and CD8+ T cells (14). Furthermore, 
analyses of renal transplant biopsies from patients indicated that 
high density of DCs was associated with increased proliferation of 
T cells and the poor outcomes (15). On the other hand, increasing 
evidence also showed that some subsets of DCs were immuno-
suppressive and could induce tolerance (16). Therefore, DCs play 
dual roles in alloimmune responses. DCs with immunoregulatory 
function were also known as tolerogenic DCs (Tol-DCs) as IDO-
expressing Tol-DCs suppressed allograft rejection and prolonged 
recipient survival after small bowel and cardiac transplantation 
(17). These studies suggest that DCs mediate allograft rejection 
while IDO-expressing DCs or Tol-DCs are capable of suppressing 
allograft rejection or inducing transplant tolerance.
It has been reported that CS interferes with DC function. 
Previous studies on airway inflammation have shown that CS 
increases the number of DCs (18), promotes the trafficking and 
function of DCs (19, 20) and, therefore, induces allergic airway 
inflammation. We have previously found that SHS suppresses 
intragraft IDO expression and reverses long-term allograft sur-
vival induced by costimulatory blockade in a murine model (12). 
Since IDO is mainly expressed by DCs, these studies indicate that 
smoking is likely to aggravate transplantation rejection by either 
stimulating the frequency and function of DCs or repressing their 
IDO expression. However, other studies have shown that CS is 
associated with impaired DC maturation and lower capacity of 
DCs to stimulate T cell proliferation (21). Le Rouzic et al. found 
that CS exposure was associated with an inhibition of DC capacity 
to activate antigen-specific T-cell response, resulting in defective 
pro-Th1 and -Th17 responses to bacteria in chronic obstructive 
pulmonary disease (COPD) patients (22). These studies demon-
strated that CS weakened immunity. Therefore, CS likely exerts 
dual effects on DCs. It remains to be defined how CS influences 
allograft rejection by altering DC function.
cD4+ cD25+ treGs
It is well known that Tregs play a key role in maintaining the 
immunologic self-tolerance and regulating immune responses 
to exogenous antigens in case of excessive immune reactions. 
Alterations in either functionality or number of Tregs may result 
in autoimmune diseases or loss of transplantation tolerance. 
Transfer of CD4+ CD25+ Tregs not only suppresses allograft 
rejection and graft-versus-host disease but also promotes trans-
plant tolerance induction. While it is unclear whether CS alters 
Treg numbers and function in the context of transplantation, 
previous studies have revealed a significant downregulation 
of CD4+ CD25+ Treg cell numbers in bronchoalveolar lavage 
fluid and blood of smoking patients with COPD compared with 
healthy non-smokers (23, 24). Since our previous studies have 
demonstrated that second-hand smoke reduces the expression 
and activity of IDO in an allograft (12), it is likely that smoking 
also inhibits Treg generation in the context of transplantation, 
because IDO generally promotes Treg development and activa-
tion (25). It is also possible that CS suppresses the generation of 
Tregs or reduces their stability via increasing pro-inflammatory 
cytokine IL-6 (26), which has been shown to destabilize FoxP3 
expression.
MeMOrY t ceLLs
Memory T cells can rapidly initiate alloimmune responses through 
the production of pro-inflammatory or effector cytokines (27). 
Previous studies also have revealed that trafficking limitation of 
memory CD4+ T cells by sphingosine 1-phosphate receptor-1 
agonist delays transplant rejection and improves survival of 
cardiac allografts (28). Similarly, depletion of CD8+ memory T 
cells using an anti-CD8 antibody was reported to be an effective 
approach to inducing allograft tolerance in non-human primates 
that have undergone kidney transplantation (29). Acute rejection 
of a liver transplant in patients was associated with proliferation 
of CD8+ memory T cells infiltrating the allograft and with their 
increased expression of IFN-γ and IL-17 (30). Hence, memory T 
cells were considered to be a major barrier to long-term allograft 
survival or transplant tolerance (31). As mounting evidence has 
shown that either active or passive CS significantly increases 
the numbers of memory CD4+ T cells (32, 33), we propose that 
smoking stimulates cross-reactive memory T cells, which in turn 
accelerate allograft rejection or at least interfere with transplant 
tolerance induction.
MeMOrY B ceLLs
It is well accepted that both memory T and memory B cells pre-
vent the long-term survival of transplanted organs and hinder 
the induction of transplant tolerance. Thus, much attention 
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has been paid to the actual effects of memory B cells and 
alloantibodies on transplant rejection. Using a murine model of 
cardiac transplantation, Burns et al. found that allograft survival 
induced by costimulatory blockade was prevented by memory 
B cells and alloantibodies of recipients (34), while alloantibod-
ies hindered transplant tolerance induction through priming 
alloreactive T cells (35). Given that memory B cells reportedly 
posed a long-term threat to allograft survival and that CS 
increased class-switched memory B cells in peripheral blood of 
current smokers and IgG+ memory B cells in the lung of COPD 
patients (36, 37), we propose that CS prevents allograft tolerance 
induction via enhancing either cross-reactive or allospecific B 
cell memory.
eFFects OF cHeMicAL cOMPONeNts 
OF ciGArette sMOKe ON iMMUNitY 
Or iMMUNe tOLerANce
Cigarette smoke contains large amounts of toxic components, 
including carbon monoxide (CO), nicotine, nitrogen oxides, and 
cadmium. These harmful toxins alter the immune homeostasis 
in oral or airway mucosa and solid organs, resulting in regional 
inflammation and abnormal immune responses to exogenous 
antigens. However, emerging evidence has shown that CO and 
nicotine, two of the major cigarette smoke components, are 
generally immunosuppressive. Therefore, they could suppress 
allograft rejection or promote transplant tolerance induction 
(Figure 1).
cArBON MONOXiDe
Carbon monoxide is produced when the heme is catalyzed by 
the enzyme heme oxygenase-1 (HO-1) expressed in immune 
cells (38), and it has been shown to exert immunosuppressive 
and antiapoptotic effects in animal studies. CO also suppresses 
alloimmune responses and allograft rejection. It was reported 
that either gene transfer of HO-1 or delivery of CO suppressed 
chronic rejection of cardiac xenografts (39). CO treatments 
prolonged survival of islet allografts, decreased expression of 
some pro-inflammatory and pro-apoptotic genes, and reduced 
macrophage infiltration in the grafts (40). Interestingly, CO 
was capable of maintaining peripheral tolerance by inducing 
CD4+ CD25+ Tregs (41). Therefore, either enhancing HO-1 
expression or directly delivering CO ameliorated ischemia/
reperfusion injury and graft rejection, alleviated chronic allo-
graft failure, and facilitated donor-specific allograft tolerance 
(39, 42, 43).
However, it is unclear why smoking, which also produces CO, 
has not been found to prolong allograft survival. Instead, it is well 
accepted that smoking generally promotes transplant rejection 
and even hinders the induction of long-term transplant survival 
or tolerance. Perhaps, CS itself does not provide transplanted 
smokers a significant amount of CO that is sufficient for sup-
pressing vigorous alloimmunity. It is also possible that smoking 
generates a mixture of hazardous materials that cooperate to 
hinder long-term allograft survival. In other words, beneficial 
effects of CO on allograft survival may be well offset by other 
harmful substances contained in cigarette smoke. Therefore, 
how smoking-generated CO exerts its effects on alloimmunity 
and allograft survival in smokers remains unclear and deserves 
further investigations.
NicOtiNe
Similarly, an immunosuppressive feature of nicotine, another 
major component of cigarette smoke, was reported in several 
animal studies in vitro and in vivo (44, 45). For instance, nico-
tine suppressed lung Th2 responses (44), DC activation, and 
host responses to vaccination (45). Importantly, continuous 
nicotine treatments also induced T cell anergy (46). Early stud-
ies using animals demonstrated that nicotine promoted the 
revascularization of an autograft in the anterior chamber of rat 
eyes after bone transplantation (47). Studies using pulmonary 
transplant models also revealed that nicotine treatments sig-
nificantly reduced the infiltration of CD68+ macrophage-like 
cells within pulmonary allografts and decreased the produc-
tion of inducible NO synthase in alveolar macrophages (48), 
indicating that nicotine possibly ameliorates acute transplant 
rejection. On the other hand, Nordman et  al. found that 
nicotine increased CD3+ CD4+ T cell numbers in circulation 
through activation of α4 nicotinic acetylcholine receptor (α4 
nAChR) on T cells and especially promoted a Th2 response 
(49), which could affect transplant survival. Therefore, it 
remains unknown how nicotine alters immune-based rejection 
of a solid allograft, although it has been shown to be mostly 
immunosuppressive. However, nicotine could promote trans-
plant tolerance induction since it was shown to induce T cell 
anergy. Further studies are warranted to determine whether 
and how nicotine regulates alloimmune responses and alters 
transplantation outcomes.
tHe MOLecULAr MecHANisMs 
UNDerLYiNG sMOKiNG-AssOciAteD 
iMMUNOPAtHOLOGY
To further understand the effects of CS on alloimmunity and 
allograft rejection, it is important to know the molecular mecha-
nisms by which smoking acts on the immune cells. Apart from 
CO and nicotine, cigarette smoke contains considerable adverse 
chemicals, including reactive nitrogen species (RNS), reac-
tive oxygen species (ROS), and free radicals. These biohazards 
contribute to inflammation, oxidative stress, and DNA damage. 
On the other hand, toll-like receptors (TLRs) expressed in innate 
immune cells are critical for recognizing exogenous pathogens. 
Previous studies presented the evidence that CS triggered 
the acute inflammation via TLR4/MYD88 signaling pathway 
(50). It was also shown that smoking altered the expression 
profile of pro-inflammatory cytokines and chemokines through 
regulating signaling pathways and activities of some transcrip-
tion factors. NFκB activation induced by oxidative stress from 
the smoke increased cyclooxygenase-2 and IL-8 expression 
(51, 52). Cigarette smoke extracts were also reported to promote 
FiGUre 2 | A molecular model of pro-inflammatory signaling 
pathways activated by cigarette smoking. Combustion products of 
cigarette smoke, including free radicals, carbon monoxide, reactive oxygen 
species, and reactive nitrogen species, can phosphorylate p38 mitogen-
activated protein kinase and ERK1/2 signaling pathways, activate NFκB, and 
alter histone modification, resulting in aberrant expression of pro-
inflammatory genes, subsequent inflammation and DNA damage, etc.
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phosphorylation of ERK1/2 and p38 mitogen-activated protein 
kinase (MAPK) and activation of their downstream pathways 
(Figure  2), leading to altered expression of heme oxygenase-1 
(HO-1), IL-12, and IL-23 as well as IL-8 (53–55). Recently, it 
was demonstrated that ATP-P2X7-inflammasome-caspase 1-IL-
1/18 axis played a role in smoke-induced airway inflammation 
in healthy smokers or COPD patients as well as murine COPD 
models, with increased activation of P2X7 receptor/caspase 1 
and elevated IL-1β and IL-18 levels (56). In that study, it was 
found that the inflammasome-associated proteins ASC and 
NALP3 were required for IL-1β and IL-18 production induced 
by smoking (57). Furthermore, smoking exerted its influence 
on chromatin structures via mediating histone modification 
in pro-inflammatory macrophages (58), possibly resulting in 
abnormal gene transcriptions. Finally, Maldifassi et al. found that 
nicotine, through stimulation of α7 nicotinic acetylcholine recep-
tor (α7 nAChR), played an anti-inflammatory role in human 
macrophages by upregulating the expression of interleukin-1 
receptor-associated kinase M (IRAK-M), a negative regulator 
of innate TLR-mediated immune responses (59). They also 
provided evidence that activation of STAT3, through a single 
(JAK2/PI3K/STAT3) or two convergent cascades (JAK2/STAT3 
and PI3K/STAT3), is required for nicotine-induced upregulation 
of IRAK-M expression (59).
Taken together, the signaling pathways and molecular mecha-
nisms underlying CS-mediated immunopathology, especially 
transplant rejection, are still not well understood due to the 
functional complexity and diversity of cigarette smoke compo-
nents. Further investigations are warranted to understand the 
molecular mechanisms of their action, especially those involved 
in alloimmune responses.
cONcLUDiNG reMArK/OPiNiON
Smoking plays dual roles in immune responsiveness due to 
the molecular and functional diversities of cigarette smoke 
components, including RNS, ROS, CO, and nicotine. However, 
numerous experimental and clinical studies have shown that CS 
exerts a deleterious rather than beneficial effect on transplant 
survival even if CS downregulates immune responses under 
certain circumstances, for instance, smoking suppresses the 
immune system by reducing lymphocyte numbers in the blood 
of patients with chronic renal failure (60). Therefore, our view 
is that smoking hinders long-term allograft survival by stimu-
lating T or B cell memory, suppressing Tol-DC development, 
or downregulating Treg cell numbers. Although combustion 
of cigarette produces CO and nicotine that are immunosup-
pressive, we think that the amount of CO and nicotine inhaled 
during smoking may not be sufficient to suppress vigorous 
allograft rejection. While previous studies have revealed some 
molecular mechanisms by which cigarette smoke alters immune 
responsiveness and mediates immunopathology, including 
P2X7-inflammasome-caspase 1-IL-1/18 axis, phosphorylation 
of ERK1/2 and p38 MAPK, and activation of NFκB in immune 
cells, the exact molecular mechanisms underlying smoking-
associated transplant rejection remain largely unknown. Further 
studies are warranted to understand why smoking accelerates 
allograft rejection even if cigarette smoke components contain 
immunosuppressive substances, such as CO and nicotine, which 
would otherwise induce CD4+ CD25+ Tregs, promote T cell 
anergy, or suppress alloimmune responses. Hence, it is possible 
that the amount of CO or nicotine absorbed by smokers during 
smoking is insufficient to suppress allograft rejection. There 
is also a possibility that the inflammation and oxidative stress 
induced by other components of CS, such as RNS, ROS, and free 
radicals, can largely outweigh any potential immunosuppressive 
action of CO and nicotine.
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